Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Benchling, OpenAI, and 370+ companies. 5-min read every Tuesday.
Benchling is the R&D cloud platform for life sciences teams to design, track, and analyze experiments — the operating system for biotech and pharmaceutical R&D globally. Valued at $6.1B with $500M+ raised, Benchling is used by 10 of the top 20 pharmaceutical companies including Pfizer, Novartis, and Regeneron. Major healthtech IPO candidate competing with Schrödinger and Dotmatics in the $30B+ life sciences software market.
| Industry | Biotechnology |
| Stage | Series F |
| IPO Status | Pre-IPO |
| Valuation | $6.1B |
| Total Funding | $260M |
| Headquarters | San Francisco, CA |
OpenAI is valued at $852B — the world's most valuable AI company, backed by $27B in funding. Track IPO readiness score, funding rounds, and timeline.
| Industry | Artificial Intelligence |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $852B |
| Total Funding | $55.4B |
| Headquarters | San Francisco, CA |
Benchling is valued at $6.1B. OpenAI is valued at $852B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
Benchling has raised $260M. OpenAI has raised $55.4B.
Benchling is currently pre-IPO. OpenAI is currently pre-IPO. Track both on TechStackIPO for S-1 filings and IPO announcements.
Benchling operates in Biotechnology, while OpenAI operates in Artificial Intelligence.
Benchling is a Biotechnology company valued at $6.1B with $260M raised. OpenAI is a Artificial Intelligence company valued at $852B with $55.4B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in Benchling and OpenAI through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.